M:
M07:
M07K:	INDEXING SCHEME RELATING TO PEPTIDES
M07K1/00:	General methods for the preparation of peptides [N: i.e. processes for the organic chemical preparation of peptides or proteins of any length]
M07K1/00A:	. [N: by transforming the C-terminal amino acid to amides]
M07K1/00B:	. of peptides containing derivatised side chain amino acids
M07K1/02:	. in solution C07K1/00A, C07K1/00B take precedence
M07K1/02A:	. . using racemisation inhibiting agents
M07K1/02B:	. . [N: by fragment condensation in solution]
M07K1/04:	. on carriers C07K1/00A, C07K1/00B take precedence
M07K1/04A:	. . characterised by the nature of the carrier
M07K1/04B:	. . using devices to improve synthesis, e.g. reactors, special vessels
M07K1/04C:	. . Simultaneous synthesis of different peptide species; Peptide libraries
M07K1/06:	. using protecting groups or activating agents C07K1/00A, C07K1/00B take precedence
M07K1/06A:	. . using protecting groups
M07K1/06A1:	. . . for alpha- or omega-carboxy functions
M07K1/06A2:	. . . for alpha-amino functions
M07K1/06A3:	. . . for omega-amino or -guanidino functions
M07K1/06A4:	. . . for hydroxy functions, not being part of carboxy functions
M07K1/06A5:	. . . for omega-amido functions
M07K1/06A6:	. . . for sulfur-containing functions
M07K1/06A7:	. . . for heterocyclic side chains
M07K1/08:	. . using activating agents C07K1/00A, C07K1/00B take precedence
M07K1/08A:	. . . containing phosphorus
M07K1/08B:	. . . containing nitrogen
M07K1/08C:	. . . containing sulfur
M07K1/08D:	. . . containing other elements, e.g. B, Si, As
M07K1/10:	. using coupling agents C07K1/00B takes precedence
M07K1/107:	. by chemical modification of precursor peptides
M07K1/107D:	. . by covalent attachment of residues or functional groups
M07K1/107D2:	. . . by covalent attachment of amino acids or peptide residues
M07K1/107D4:	. . . by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
M07K1/113:	. . without change of the primary structure
M07K1/113B:	. . . [N: by redox-reactions involving cystein/cystin side chains]
M07K1/113D:	. . . [N: by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents]
M07K1/12:	. by hydrolysis i.e. solvolysis in general
M07K1/12A:	. . Hydrolysis with acids different from HF
M07K1/12C:	. . Hydrazinolysis
M07K1/12D:	. . Aminolysis
M07K1/12E:	. . [N: sequencing]
M07K1/13:	. Labelling of peptides
M07K1/14:	. Extraction; Separation; Purification
M07K1/14A:	. . [N: by extraction or solubilisation]
M07K1/16:	. . by chromatography
M07K1/16A:	. . . [N: mixed-mode chromatography]
M07K1/18:	. . . Ion-exchange chromatography
M07K1/20:	. . . Partition-, reverse-phase or hydrophobic interaction chromatography
M07K1/22:	. . . Affinity chromatography or related techniques based upon selective absorption processes
M07K1/24:	. . by electrochemical means
M07K1/26:	. . . Electrophoresis
M07K1/28:	. . . . Isoelectric focusing
M07K1/28A:	. . . . . [N: multi dimensional electrophoresis]
M07K1/30:	. . by precipitation
M07K1/30A:	. . . [N: by salting out]
M07K1/30B:	. . . [N: by crystallization]
M07K1/32:	. . . as complexes
M07K1/34:	. . by filtration, ultrafiltration or reverse osmosis
M07K1/36:	. . by a combination of two or more processes of different types
M07K2/00:	Peptides of undefined number of amino acids; Derivatives thereof
M07K4/00:	Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
M07K4/02:	. from viruses
M07K4/04:	. from bacteria
M07K4/06:	. from fungi
M07K4/08:	. from algae; from lichens
M07K4/10:	. from plants
M07K4/12:	. from animals; from humans
M07K5/00:	Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
M07K5/02:	. containing at least one abnormal peptide link
M07K5/02A:	. . containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
M07K5/02B:	. . containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
M07K5/02C:	. . containing the structure -NH-(X)4-C(=0), e.g. `isosters`, replacing two amino acids
M07K5/02D:	. .  6, classification in C07K5/06 to C07K5/10, according to the moiety having normal peptide bonds
M07K5/02E:	. . containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
M07K5/02F:	. . containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
M07K5/02G:	. . containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
M07K5/02H:	. . containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
M07K5/02H1:	. . . [N: with the first amino acid being heterocyclic, e.g. Pro, Trp]
M07K5/02J:	. . containing the structure -N-C-C(=O)-N-C(=O)-C-N-
M07K5/02L:	. .  6 see C07K5/06 to C07K5/10
M07K5/04:	. containing only normal peptide links
M07K5/06:	. . Dipeptides
M07K5/06A:	. . . with the first amino acid being neutral
M07K5/06A1:	. . . . and aliphatic
M07K5/06A1A:	. . . . . the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
M07K5/06A1B:	. . . . . the side chain containing 2 to 4 carbon atoms
M07K5/06A1B1:	. . . . . . Leu-amino acid
M07K5/06A1B2:	. . . . . . Val-amino acid
M07K5/06A1F:	. . . . . the side chain containing heteroatoms not provided for by C07K5/06B to C07K5/06H , e.g. Ser, Met, Cys, Thr
M07K5/06A1F1:	. . . . . . Ser-amino acid
M07K5/06A2:	. . . . [N: and aromatic or cycloaliphatic]
M07K5/06B:	. . . with the first amino acid being basic
M07K5/06B1:	. . . . Arg-amino acid
M07K5/06C:	. . . with the first amino acid being acidic
M07K5/06C1:	. . . . Asp- or Asn-amino acid
M07K5/06C1A:	. . . . . the second amino acid being aromatic or cycloaliphatic
M07K5/06C1A1:	. . . . . . Aspartame
M07K5/06H:	. . . with the first amino acid being heterocyclic
M07K5/06H3:	. . . . [N: and His-amino acid; derivatives thereof]
M07K5/06H5:	. . . . [N: and Trp-amino acid; Derivatives thereof ]
M07K5/06H6:	. . . . [N: and Pro-amino acid; Derivatives thereof]
M07K5/06H7:	. . . . and Glp-amino acid; Derivatives thereof
M07K5/06H8:	. . . . [N: and Pristinamycin II; Derivatives thereof]
M07K5/06T:	. . . [N: containing heteroatoms different from O, S, or N ]
M07K5/08:	. . Tripeptides
M07K5/08A:	. . . with the first amino acid being neutral
M07K5/08A1:	. . . . and aliphatic
M07K5/08A1A:	. . . . . the side chain containing 0 or 1 carbon atoms, i.e. Gly, Alc
M07K5/08A1B:	. . . . . the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
M07K5/08A1F:	. . . . . the side chain containing O or S as heteroatoms, e.g. Cys, Ser
M07K5/08A2:	. . . . and aromatic or cycloaliphatic
M07K5/08B:	. . . with the first amino acid being basic
M07K5/08B1:	. . . . the first amino acid being Arg
M07K5/08C:	. . . with the first amino acid being acidic
M07K5/08H:	. . . [N: with the first amino acid being heterocyclic, e.g. His, Pro, Trp]
M07K5/08H4:	. . . . [N: and Pro-amino acid; Derivatives thereof]
M07K5/08H5:	. . . . [N: and Glp-amino acid; Derivatives thereof]
M07K5/08T:	. . . [N: containing heteroatoms different from O, S, or N ]
M07K5/10:	. . Tetrapeptides
M07K5/10A:	. . . with the first amino acid being neutral
M07K5/10A1:	. . . . and aliphatic
M07K5/10A1A:	. . . . . the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
M07K5/10A1B:	. . . . . the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
M07K5/10A1F:	. . . . . the side chain containing O or S as heteroatoms, e.g. Cys, Ser
M07K5/10A2:	. . . . and aromatic or cycloaliphatic
M07K5/10B:	. . . with the first amino acid being basic
M07K5/10C:	. . . with the first amino acid being acidic
M07K5/10H:	. . . with the first amino acid being heterocyclic
M07K5/10T:	. . . [N: containing heteroatoms different from O, S, or N ]
M07K5/12:	. . Cyclic peptides [N: with only normal peptide bonds in the ring]
M07K5/12A:	. . . Tripeptides
M07K5/12B:	. . . Tetrapeptides
M07K7/00:	Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
M07K7/02:	. Linear peptides containing at least one abnormal peptide link
M07K7/04:	. Linear peptides containing only normal peptide links
M07K7/06:	. . having 5 to 11 amino acids
M07K7/06D:	. . . Serum thymic factor
M07K7/06E:	. . . Thymic humoral factor
M07K7/06F:	. . . Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
M07K7/08:	. . having 12 to 20 amino acids
M07K7/08C:	. . . Neurotensin
M07K7/08D:	. . . Bombesin; Related peptides having more than 20 amino acids C07K14/575M
M07K7/14:	. . Angiotensins: Related peptides
M07K7/16:	. . Oxytocins; Vasopressins; Related peptides
M07K7/18:	. . Kallidins; Bradykinins; Related peptides
M07K7/22:	. . Tachykinins, e.g. Eledoisins, Substance P ; Related peptides
M07K7/23:	. . Luteinising hormone-releasing hormone (LHRH); Related peptides
M07K7/28:	. . Gramicidins A, B, D; Related peptides
M07K7/50:	. Cyclic peptides containing at least one abnormal peptide link
M07K7/52:	. . with only normal peptide links in the ring
M07K7/54:	. . with at least one abnormal peptide link in the ring
M07K7/56:	. . . the cyclisation not occuring through 2,4-diamino-butanoic acid
M07K7/58:	. . . . Bacitracins; Related peptides
M07K7/60:	. . . the cyclisation occuring through the 4-amino group of 2,4-diamino-butanoic acid
M07K7/62:	. . . . Polymyxins; Related peptides
M07K7/64:	. Cyclic peptides containing only normal peptide links
M07K7/64A:	. . Cyclosporins; Related peptides
M07K7/66:	. . Gramicidins S, C; Tyrocidins A,B,C; Related peptides
M07K9/00:	Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
M07K9/00D:	. the peptide sequence having less than 12 amino acids and not being part of a ring structure
M07K9/00D2:	. . Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
M07K9/00D4:	. .  0, A,B,D,E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
M07K9/00F:	. the peptide sequence being part of a ring structure
M07K9/00F2:	. . directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
M07K11/00:	Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
M07K11/02:	. cyclic, e.g. valinomycins Derivatives thereof
M07K14/00:	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
M07K14/005:	. from viruses
M07K14/00B:	. by chemical synthesis
M07K14/00B1:	. . Peptide-nucleic acids (PNAs)
M07K14/01:	. . DNA viruses
M07K14/015:	. . . Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
M07K14/02:	. . . Hepadnaviridae, e.g. hepatitis B virus
M07K14/025:	. . . Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
M07K14/03:	. . . Herpetoviridae, e.g. pseudorabies virus
M07K14/035:	. . . . Herpes simplex virus I or II
M07K14/03B:	. . . . Pseudorabies virus, i.e. Anjetzky virus
M07K14/04:	. . . . Varicella-zoster virus
M07K14/045:	. . . . . Cytomegalovirus
M07K14/05:	. . . . Epstein-Barr virus
M07K14/055:	. . . . Marek`s disease virus
M07K14/06:	. . . . Infectious bovine rhinotracheitis virus
M07K14/065:	. . . Poxviridae, e.g. avipoxvirus
M07K14/07:	. . . . Vaccinia virus; Variola virus
M07K14/075:	. . . Adenoviridae
M07K14/08:	. . RNA viruses
M07K14/085:	. . . Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
M07K14/08C:	. . . Arteriviridae, e.g. EAV, PRRSV
M07K14/09:	. . . . Foot-and-mouth disease virus
M07K14/095:	. . . . Rhinovirus
M07K14/10:	. . . . Hepatitis A virus
M07K14/105:	. . . . Poliovirus
M07K14/11:	. . . Orthomyxoviridae, e.g. influenza virus
M07K14/115:	. . . Paramyxoviridae, e.g. parainfluenza virus
M07K14/12:	. . . . Mumps virus; Measles virus
M07K14/125:	. . . . Newcastle disease virus
M07K14/13:	. . . . Canine distemper virus
M07K14/135:	. . . . Respiratory syncytial virus
M07K14/14:	. . . Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
M07K14/145:	. . . Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokda virus, vesicular stomatitis virus
M07K14/15:	. . . Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
M07K14/155:	. . . . Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
M07K14/16:	. . . . . HIV-1; HIV-2
M07K14/165:	. . . Coronaviridae, e.g. avian infectious bronchitis virus
M07K14/16B:	. . . . . . gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40
M07K14/16D:	. . . . . . env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site
M07K14/16F:	. . . . . . Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
M07K14/17:	. . . . Porcine transmissible gastroenteritis virus
M07K14/175:	. . . Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus
M07K14/18:	. . . Togaviridae; Flaviviridae
M07K14/18A:	. . . . Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE, semliki forest virus rubella virus C07K14/19
M07K14/18F:	. . . . Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
M07K14/18F2:	. . . . . Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
M07K14/18F4:	. . . . . Hepatitis C; Hepatitis NANB
M07K14/18F6:	. . . . . Hepatitis G; Hepatitis NANBNCNDNE
M07K14/19:	. . . . Rubella virus
M07K14/195:	. from bacteria
M07K14/20:	. . from Spirochaetales (O), e.g. Treponema, Leptospira
M07K14/205:	. . from Campylobacter (G)
M07K14/21:	. . from Pseudomonadaceae (F)
M07K14/215:	. . from Halobacteriaceae (F)
M07K14/21B:	. . . Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
M07K14/22:	. . from Neisseriaceae (F)
M07K14/225:	. . from Alcaligenes (G)
M07K14/23:	. . from Brucella (G)
M07K14/235:	. . from Bordetella (G)
M07K14/24:	. . from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
M07K14/245:	. . . Escherichia (G)
M07K14/25:	. . . Shigella (G)
M07K14/255:	. . . Salmonella (G)
M07K14/26:	. . . Klebsiella (G)
M07K14/265:	. . . Enterobacter (G)
M07K14/27:	. . . Erwinia (G)
M07K14/275:	. . . Hafnia (G)
M07K14/28:	. . from Vibrionaceae (F)
M07K14/285:	. . from Pasteurellaceae (F), e.g. Haemophilus influenza
M07K14/29:	. . from Richettsiales (o)
M07K14/295:	. . from Chlamydiales (o)
M07K14/30:	. . from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO)
M07K14/305:	. . from Micrococcaceae (F)
M07K14/31:	. . . from Staphylococcus (G)
M07K14/315:	. . from Streptococcus (G), e.g. Enterococci
M07K14/315A:	. . . Streptokinase
M07K14/315B:	. . . from Streptococcus pneumoniae (Pneumococcus) Streptokinase C07K14/315A
M07K14/32:	. . from Bacillus (G)
M07K14/325:	. . . Bacillus thuringiensis crystal protein (delta-endotoxin)
M07K14/33:	. . from Clostridium (G)
M07K14/335:	. . from Lactobacillus (G)
M07K14/34:	. . from Corynebacterium (G)
M07K14/345:	. . from Brevibacterium (G)
M07K14/35:	. . from Mycobacteriaceae (F)
M07K14/355:	. . from Nocardia (G)
M07K14/36:	. . from Actinomyces; from Streptomyces (G)
M07K14/365:	. . from Actinoplanes (G)
M07K14/37:	. from fungi
M07K14/375:	. . from Basidiomycetes
M07K14/38:	. . from Aspergillus
M07K14/385:	. . from Penicillium
M07K14/39:	. . from yeasts
M07K14/395:	. . . from Saccharomyces
M07K14/40:	. . . from Candida
M07K14/405:	. from algae
M07K14/41:	. from lichens
M07K14/415:	. from plants
M07K14/42:	. . Lectins, e.g. concanavalin, phytohaemagglutinin
M07K14/425:	. . Zeins
M07K14/43:	. . Sweetening agents, e.g. thaumatin, monellin
M07K14/435:	. from animals; from humans
M07K14/435A:	. . from invertebrates
M07K14/435A1:	. . . from crustaceans
M07K14/435A2:	. . . from arachnidae
M07K14/435A2A:	. . . . from spiders
M07K14/435A2B:	. . . . from scorpions
M07K14/435A2C:	. . . . from ticks
M07K14/435A2D:	. . . . from mites
M07K14/435A3:	. . . from worms
M07K14/435A3A:	. . . . from nematodes
M07K14/435A3A1:	. . . . . from Caenorhabditis
M07K14/435A3B:	. . . . from cestodes
M07K14/435A3B1:	. . . . . from Taenia
M07K14/435A3C:	. . . . from trematodes
M07K14/435A4:	. . . from insects
M07K14/435A4B:	. . . . from wasps
M07K14/435A4C:	. . . . from bees
M07K14/435A4D:	. . . . from flies
M07K14/435A4D1:	. . . . . from Drosophila
M07K14/435A4E:	. . . . from silkworms [M1204]
M07K14/435A4G:	. . . . from fleas
M07K14/435A5:	. . . from coelenteratae, e.g. medusae
M07K14/44:	. . from protozoa
M07K14/445:	. . . Plasmodium
M07K14/45:	. . . Toxoplasma
M07K14/455:	. . . Eimeria
M07K14/46:	. . from vertebrates
M07K14/465:	. . . from birds
M07K14/46A:	. . . from fish
M07K14/46B:	. . . from amphibians
M07K14/47:	. . . from mammals
M07K14/475:	. . Growth factors; Growth regulators
M07K14/475A:	. . . Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
M07K14/475B:	. . . Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
M07K14/47A:	. . . . not used
M07K14/47A1:	. . . . . Regulators; Modulating activity
M07K14/47A11:	. . . . . Complement proteins, e.g. anaphylatoxin, C3a, C5a
M07K14/47A12:	. . . . . Lipocortins
M07K14/47A13:	. . . . . G-proteins
M07K14/47A14:	. . . . . Cationic antimicrobial peptides, e.g. defensins
M07K14/47A15:	. . . . . Proteoglycans, e.g. aggreccan
M07K14/47A16:	. . . . . Lectins
M07K14/47A17:	. . . . . Mucins, e.g. human intestinal mucin
M07K14/47A18:	. . . . . Calcium binding proteins, e.g. calmodulin
M07K14/47A19:	. . . . . alpha-Glycoproteins
M07K14/47A1A:	. . . . . . Inhibitors; Supressors
M07K14/47A1B:	. . . . . . stimulating, promoting or activating activity
M07K14/47A1B1:	. . . . . . . Guanosine triphosphatase activating protein, GAP
M07K14/47A2:	. . . . . Muscular dystrophy
M07K14/47A20:	. . . . . Recognins, e.g. malignin
M07K14/47A21:	. . . . . Casein in foodstuffs A23J
M07K14/47A22:	. . . . . Acute pancreatitis-associated protein
M07K14/47A23:	. . . . . Villin
M07K14/47A24:	. . . . . Retinoblastoma protein
M07K14/47A25:	. . . . . C-reactive protein
M07K14/47A26:	. . . . . Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR cell cycle dependent kinases C12N9/12B1
M07K14/47A27:	. . . . . Pancreatic thread protein; Reg protein
M07K14/47A28:	. . . . . Keratin; Cytokeratin
M07K14/47A29:	. . . . . Bactericidal/Permeability-increasing protein (BPI)
M07K14/47A2A:	. . . . . . Duchenne dystrophy
M07K14/47A2B:	. . . . . . Myotonic dystrophy
M07K14/47A3:	. . . . . Alzheimer`s disease; Amyloid plaque core protein
M07K14/47A30:	. . . . . Insulin-like growth factor binding protein
M07K14/47A31:	. . . . . Cancer-associated SCM-recognition factor, CRISPP
M07K14/47A32:	. . . . . p53
M07K14/47A33:	. . . . . Apoptosis related proteins
M07K14/47A34:	. . . . . Tumour specific antigens; Tumour rejection antigen precursors (TRAP), e.g. MAGE
M07K14/47A4:	. . . . . Cystic fibrosis
M07K14/47A5:	. . . . . Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
M07K14/47A6:	. . . . . Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
M07K14/47A7:	. . . . . Muscle proteins, e.g. myosin, actin [M1204]
M07K14/47A8:	. . . . . Plasma globulins, lactoglobulin
M07K14/47A9:	. . . . . Cytokine-induced proteins
M07K14/48:	. . . Nerve growth factor (NGF)
M07K14/485:	. . . Epidermal growth factor (EGF) (urogastrone)
M07K14/49:	. . . Platelet-derived growth factor (PDGF)
M07K14/495:	. . . Transforming growth factor (TGF)
M07K14/50:	. . . Fibroblast growth factors (FGF)
M07K14/505:	. . . Erythropoietin (EPO)
M07K14/50A:	. . . . acidic FGF (aFGF)
M07K14/50B:	. . . . basic FGF (bFGF)
M07K14/51:	. . . Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
M07K14/515:	. . . Angiogenesic factors; Angiogenin
M07K14/52:	. . Cytokines; Lymphokines; Interferons
M07K14/525:	. . . Tumor necrosis factor (TNF)
M07K14/525B:	. . . . Lymphotoxin (LT)
M07K14/52A:	. . . Chemokines
M07K14/52A1:	. . . . Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
M07K14/52A2:	. . . . Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
M07K14/52B:	. . . Thrombopoietin, i.e. C-MPL ligand
M07K14/53:	. . . Colony-stimulating factor (CSF)
M07K14/535:	. . . . Granulocyte CSF; Granulocyte-macrophage CSF
M07K14/54:	. . . Interleukins (IL)
M07K14/545:	. . . . IL-1
M07K14/54A:	. . . . IL-3
M07K14/54B:	. . . . IL-4
M07K14/54C:	. . . . IL-5
M07K14/54D:	. . . . IL-6
M07K14/54E:	. . . . Leukaemia inhibitory factor (LIF)
M07K14/54F:	. . . . IL-7
M07K14/54G:	. . . . IL-8
M07K14/54H:	. . . . IL-9
M07K14/54K:	. . . . IL-10
M07K14/54L:	. . . . IL-11
M07K14/54M:	. . . . IL-12
M07K14/54N:	. . . . IL-13
M07K14/54P:	. . . . IL-14
M07K14/54Q:	. . . . IL-15
M07K14/54R:	. . . . IL-16
M07K14/55:	. . . . IL-2
M07K14/555:	. . . Interferons (IFN)
M07K14/56:	. . . . IFN-alpha
M07K14/565:	. . . . IFN-beta
M07K14/57:	. . . . IFN-gamma
M07K14/575:	. . Hormones
M07K14/575B:	. . . Corticotropin releasing factor (CRF) (Urotensin)
M07K14/575D:	. . . Placental lactogen; Chorionic somatomammotropin [M1204]
M07K14/575F:	. . . Calcitonin gene related peptide
M07K14/575G:	. . . Endothelin, vasoactive intestinal contractor (VIC)
M07K14/575H:	. . . Neuropeptide Y
M07K14/575K:	. . . Prolactin
M07K14/575L:	. . . Vasoactive intestinal peptide (VIP); Related peptides
M07K14/575M:	. . . Gastrin releasing peptide bombesin C07K7/08D
M07K14/575N:	. . . Thymosin; Related peptides
M07K14/575P:	. . . Products of obesity genes, e.g. leptin, obese (OB), tub, fat
M07K14/58:	. . . Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide (ANP); Cardionatrin; Cardiodilatin
M07K14/585:	. . . Calcitonins
M07K14/585A:	. . . . at least 1 amino acid in D-form
M07K14/58A:	. . . . at least 1 amino acid in D-form
M07K14/59:	. . . Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH)
M07K14/595:	. . . Gastrins; Cholecystokinins (CCK)
M07K14/595A:	. . . . at least 1 amino acid in D-form
M07K14/59A:	. . . . at least 1 amino acid in D-form
M07K14/60:	. . . Growth-hormone releasing factors (GH-RF) (Somatoliberin)
M07K14/605:	. . . Glucagons
M07K14/61:	. . . Growth hormones (GH) (Somatotropin)
M07K14/615:	. . . . Extraction from natural sources
M07K14/62:	. . . Insulins
M07K14/625:	. . . . extraction from natural sources
M07K14/62A:	. . . . at least 1 amino acid in D-form
M07K14/63:	. . . Motilins
M07K14/635:	. . . Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
M07K14/64:	. . . Relaxins
M07K14/645:	. . . Secretins
M07K14/65:	. . . Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
M07K14/655:	. . . Somatostatins
M07K14/655A:	. . . . at least 1 amino acid in D-form
M07K14/66:	. . . Thymopoietins
M07K14/665:	. . derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
M07K14/66A:	. . . . at least 1 amino acid in D-form
M07K14/67:	. . . Lipotropins, e.g. beta, gamma lipotropin
M07K14/675:	. . . beta-Endorphins
M07K14/675A:	. . . . with at least 1 amino acid in D-form
M07K14/67A:	. . . . with at least 1 amino acid in D-form
M07K14/68:	. . . Melanocyte-stimulating hormone (MSH)
M07K14/685:	. . . . alpha-Melanotropin
M07K14/69:	. . . . beta-Melanotropin
M07K14/695:	. . . Corticotropin (ACTH)
M07K14/695A:	. . . . with at least 1 amino acid in D-form
M07K14/70:	. . . Enkephalins
M07K14/705:	. . Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/47A34
M07K14/705B:	. . . Immunoglobulin superfamily
M07K14/705B10:	. . . . CD2
M07K14/705B12:	. . . . T-cell receptor (TcR)-CD3 complex
M07K14/705B14:	. . . . CD4
M07K14/705B16:	. . . . CD8
M07K14/705B18:	. . . . CD28, CD152
M07K14/705B20:	. . . . ICAM molecules, e.g. CD50, CD54, CD102
M07K14/705B22:	. . . . CD58
M07K14/705B24:	. . . . B7 molecules, e.g. CD80, CD86
M07K14/705B26:	. . . . Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
M07K14/705B28:	. . . . MHC-molecules, e.g. HLA-molecules
M07K14/705B30:	. . . . CD106
M07K14/705D:	. . . Integrin superfamily
M07K14/705D10:	. . . . Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
M07K14/705D12:	. . . . Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
M07K14/705D14:	. . . . Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
M07K14/705F:	. . . Lectin superfamily, e.g. CD23, CD72
M07K14/705F10:	. . . . Selectins, e.g. CD62
M07K14/705G:	. . . Nuclear receptors, e.g. retinoic acid receptor (RAR), RXR, nuclear orphan receptors
M07K14/705K:	. . . for neuromediators, e.g. serotonin receptor, dopamine receptor
M07K14/705Q:	. . . NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154 NGF C07K14/48, TNF C07K14/525
M07K14/705R:	. . . NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95 NGF-receptor C07K14/71, TNF-receptor C07K14/715B
M07K14/705S:	. . . CD71
M07K14/705T:	. . . CD44
M07K14/705V:	. . . CD45
M07K14/705W:	. . . CD52
M07K14/705Z:	. . . Molecules with a "CD"-designation not provided for elsewhere
M07K14/70A:	. . . . with at least 1 amino acid in D-form
M07K14/71:	. . . for growth factors; for growth regulators
M07K14/715:	. . . for cytokines; for lymphokines; for interferons
M07K14/715B:	. . . . for tumor necrosis factor (TNF), for lymphotoxin (LT)
M07K14/715D:	. . . . for colony-stimulating factors (CSF)
M07K14/715F:	. . . . for interleukins (IL)
M07K14/715G:	. . . . for interferons (IFN)
M07K14/715H:	. . . . for chemokines
M07K14/72:	. . . for hormones for neuromediators C07K14/705K
M07K14/72A:	. . . . Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
M07K14/72B:	. . . . G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
M07K14/745:	. . Blood coagulation or fibrinolysis factors
M07K14/745B:	. . . Thrombomodulin
M07K14/75:	. . . Fibrinogen
M07K14/755:	. . . Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
M07K14/76:	. . Albumins
M07K14/765:	. . . Serum albumin, e.g. HSA
M07K14/77:	. . . Ovalbumin
M07K14/775:	. . Apolipopeptides
M07K14/78:	. . Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)
M07K14/785:	. . Alveolar surfactant peptides; Pulmonary surfactant peptides
M07K14/79:	. . Transferrins, e.g. lactoferrins, ovotransferrins
M07K14/795:	. Porphyrin- or corrin-ring-containing peptides
M07K14/80:	. . Cytochromes
M07K14/805:	. . Haemoglobins; Myoglobins
M07K14/81:	. Protease inhibitors
M07K14/815:	. . from leeches, e.g. hirudin, eglin
M07K14/81A:	. . Exopeptidase (E.C. 3.4.11-19) inhibitors
M07K14/81B:	. . Endopeptidase (E.C. 3.4.21-99) inhibitors
M07K14/81B1:	. . . Serine protease (E.C. 3.4.21) inhibitors
M07K14/81B1A:	. . . . Kunitz type inhibitors
M07K14/81B1A1:	. . . . . Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
M07K14/81B1B:	. . . . Serpins
M07K14/81B1B1:	. . . . . Alpha-1-antitrypsin
M07K14/81B1B2:	. . . . . Antithrombin III
M07K14/81B1B3:	. . . . . Plasminogen activator inhibitors
M07K14/81B1C:	. . . . Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
M07K14/81B2:	. . . Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
M07K14/81B3:	. . . Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
M07K14/81B4:	. . . Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
M07K14/82:	. Translation products from oncogenes
M07K14/825:	. Metallothioneins
M07K16/00:	Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/00B
M07K16/00A:	. constructed by phage libraries
M07K16/02:	. from eggs
M07K16/04:	. from milk
M07K16/06:	. from serum
M07K16/06A:	. . Purification, fragmentation
M07K16/08:	. against material from viruses
M07K16/08A:	. . from DNA viruses
M07K16/08A12:	. . . Hepadnaviridae, e.g. hepatitis B virus
M07K16/08A14:	. . . Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
M07K16/08A16:	. . . Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
M07K16/08A16B:	. . . . Herpes simplex virus
M07K16/08A16D:	. . . . Varicella-zoster virus, e.g. cytomegalovirus
M07K16/10:	. . from RNA viruses, e.g. hepatitis E virus
M07K16/10B:	. . . Picornaviridae, e.g. hepatitis A virus
M07K16/10D:	. . . Orthomyxoviridae, e.g. influenza virus
M07K16/10F:	. . . Paramyxoviridae, e.g. respiratory syncytial virus
M07K16/10K:	. . . Retroviridae, e.g. leukemia viruses
M07K16/10K1:	. . . . Lentiviridae, e.g. HIV, FIV, SIV
M07K16/10K1B:	. . . . . gag-pol, e.g. p17, p24
M07K16/10K1D:	. . . . . env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
M07K16/10K1F:	. . . . . Regulatory proteins, e.g. tat, rev, vpt
M07K16/10N:	. . . Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
M07K16/10N1:	. . . . Hepatitis C virus; Hepatitis G virus
M07K16/12:	. against material from bacteria
M07K16/12A:	. . from Gram-negative bacteria
M07K16/12A10:	. . . from Spirochaetales (O), e.g. Treponema, Leptospira
M07K16/12A12:	. . . from Helicobacter (Campylobacter) (G)
M07K16/12A14:	. . . from Pseudomonadaceae (F)
M07K16/12A18:	. . . from Neisseriaceae (F), e.g. Acinetobacter
M07K16/12A22:	. . . from Brucella (G)
M07K16/12A24:	. . . from Bordetella (G)
M07K16/12A26:	. . . from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
M07K16/12A26A:	. . . . from Escherichia (G)
M07K16/12A26C:	. . . . from Salmonella (G)
M07K16/12A28:	. . . from Vibrionaceae (G)
M07K16/12A30:	. . . from Pasteurellaceae (F), e.g. Haemophilus influenza
M07K16/12A32:	. . . from Rickettsiales (O)
M07K16/12A34:	. . . from Chlamydiales (O)
M07K16/12A36:	. . . from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO)
M07K16/12A38:	. . . from Bacteridaceae (F)
M07K16/12A40:	. . . from Legionella (G)
M07K16/12A42:	. . . from Rhizobiaceae (F)
M07K16/12B:	. . from Gram-positive bacteria
M07K16/12B10:	. . . from Micrococcaceae (F), e.g. Staphylococcus
M07K16/12B12:	. . . from Streptococcus (G)
M07K16/12B14:	. . . from Bacillus (G)
M07K16/12B16:	. . . from Clostridium (G)
M07K16/12B20:	. . . from Corynebacterium (G)
M07K16/12B24:	. . . from Mycobacteriaceae (F)
M07K16/12B28:	. . . from Actinomyces; from Streptomyces (G)
M07K16/12B30:	. . . from Listeria
M07K16/14:	. against material from fungi, algea or lichens
M07K16/16:	. against material from plants
M07K16/18:	. against material from animals or humans
M07K16/20:	. . from protozoa
M07K16/20A:	. . . Plasmodium
M07K16/22:	. . against growth factors; against growth regulators
M07K16/24:	. . against cytokines, lymphokines or interferons
M07K16/24B:	. . . Tumor Necrosis Factors
M07K16/24B10:	. . . . Lymphotoxin (LT)
M07K16/24D:	. . . Colony Stimulating Factors
M07K16/24F:	. . . Interleukins (IL)
M07K16/24F1:	. . . . IL-1
M07K16/24F2:	. . . . IL-2
M07K16/24F4:	. . . . IL-4
M07K16/24F6:	. . . . IL-6
M07K16/24H:	. . . Interferons
M07K16/26:	. . against hormones; against hormone releasing or inhibiting factors
M07K16/28:	. . against receptors, cell surface antigens or cell surface determinants
M07K16/28A:	. . . against the immunoglobulin superfamily
M07K16/28A10:	. . . . against CD2
M07K16/28A12:	. . . . [N. against the T-cell receptor (TcR)-CD3 complex]
M07K16/28A14:	. . . . against CD4
M07K16/28A16:	. . . . against CD8
M07K16/28A18:	. . . . against CD28 or CD152
M07K16/28A20:	. . . . against ICAM molecules, e.g. CD50, CD54, CD102
M07K16/28A22:	. . . . against CD58
M07K16/28A24:	. . . . against B7 molecules, e.g. CD80, CD86
M07K16/28A26:	. . . . against Fc-receptors, e.g. CD16, CD32, CD64 CD23 C07K16/28C
M07K16/28A28:	. . . . against MHC-molecules, e.g. HLA-molecules
M07K16/28A30:	. . . . against CD106
M07K16/28B:	. . . against the integrin superfamily
M07K16/28B10:	. . . . against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
M07K16/28B12:	. . . . against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
M07K16/28B14:	. . . . against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
M07K16/28C:	. . . against the lectin superfamily, e.g. CD23, CD72
M07K16/28C10:	. . . . against selectins, e.g. CD62
M07K16/28D:	. . . against nuclear receptors, e.g. retinoic acid receptor (RAR), RXR, orphan receptor
M07K16/28F:	. . . against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
M07K16/28G:	. . . against receptors for growth factors, growth regulators
M07K16/28H:	. . . against receptors for cytokines, lymphokines, interferons
M07K16/28K:	. . . against hormone receptors for antibodies against neuromediator receptors C07K16/28F
M07K16/28P:	. . . against prion molecules, e.g. CD230
M07K16/28Q:	. . . against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154 against NGF C07K16/22, against TNF C07K16/24B
M07K16/28R:	. . . against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
M07K16/28S:	. . . against CD71
M07K16/28T:	. . . against CD44
M07K16/28U:	. . . [N: against CD20]
M07K16/28V:	. . . against CD45
M07K16/28W:	. . . against CD52
M07K16/28Z:	. . . against molecules with a "CD"-designation, not provided for elsewhere
M07K16/30:	. . . from tumour cells
M07K16/30A:	. . . . Carcino-embryonic Antigens
M07K16/30B:	. . . . Breast
M07K16/30D:	. . . . Lung
M07K16/30F:	. . . . Liver or Pancreas
M07K16/30H:	. . . . Kidney, bladder
M07K16/30K:	. . . . Stomach, Intestines
M07K16/30L:	. . . . Skin, nerves, brain
M07K16/30M:	. . . . Blood cells
M07K16/30P:	. . . . Reproductive system, e.g. ovaria, uterus, testes, prostate
M07K16/30S:	. . . . against structure-related tumour-associated moieties
M07K16/30S10:	. . . . . against tumour-associated gangliosides
M07K16/30S20:	. . . . . against tumour-associated mucins
M07K16/32:	. . against translation products of oncogenes
M07K16/34:	. . against blood group antigens
M07K16/36:	. . against blood coagulation factors
M07K16/38:	. against protease inhibitors of peptide structure
M07K16/40:	. against enzymes
M07K16/42:	. against immunoglobulins
M07K16/42K:	. . against an idiotypic determinant on Ig
M07K16/42K10:	. . . against anti-viral Ig
M07K16/42K10A:	. . . . against anti-HIV Ig
M07K16/42K12:	. . . against anti-bacterial Ig
M07K16/42K14:	. . . against anti-human or anti-animal Ig
M07K16/42K14A:	. . . . against anti-protozoal Ig
M07K16/42K14B:	. . . . against anti-receptor Ig
M07K16/42K14B1:	. . . . . against anti-tumor receptor Ig
M07K16/42K14B2:	. . . . . against anti-CD4 Ig
M07K16/42M:	. . against an allotypic or isotypic determinant on Ig
M07K16/42M10:	. . . against IgE
M07K16/44:	. against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
M07K16/46:	. Hybrid immunoglobulins
M07K16/46B:	. . Igs containing Ig-regions, -domains or -residues form different species
M07K16/46B1:	. . . Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
M07K16/46B2:	. . . Igs containing CDR-residues from one specie grafted between FR-residues from another
M07K16/46B2B:	. . . . with additional modified FR-residues
M07K16/46B3:	. . . Igs with modifications in the FR-residues only
M07K16/46D:	. . Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
M07K17/00:	Carrier-bound or immobilised peptides ; Preparation thereof
M07K17/02:	. Peptides being immobilised on, or in, an organic carrier
M07K17/04:	. . entrapped within the carrier, e.g. gel, hollow fibre
M07K17/06:	. . attached to the carrier via a bridging agent
M07K17/08:	. . the carrier being a synthetic polymer
M07K17/10:	. . the carrier being a carbohydrate
M07K17/12:	. . . Cellulose or derivatives thereof
M07K17/14:	. Peptides being immobilised on, or in, an inorganic carrier
M07K19/00:	Hybrid peptides
M07K203/00:
M07K221/00:	Nucleic acid comprised in viral vector [N: No longer used] [N: Note: Codes M07K221/00 to 221/24 are in reorganisation, see also M12N799/02]
M07K221/12:	. Parvoviral vector [N: No longer used]
M07K221/16:	. Herpesviral vector [N: No longer used]
M07K221/20:	. Poxviral vector [N: No longer used]
M07K221/24:	. Retroviral vector [N: No longer used]
M07K221/04:	. Adenoviral vector [N: No longer used]
M07K221/08:	. Baculoviral vector [N: No longer used]
M07K299/00:	Coordinates from 3D structures of peptides, e.g. proteins or enzymes
M07K316/00:	Immunoglobulins specific feautures
M07K316/100:	. Immunoglobulins according to their source of isolation
M07K316/110:	. . isolated from eggs
M07K316/120:	. . isolated form milk
M07K316/130:	. . isolated from plants
M07K316/200:	. Immunoglobulins, or parts thereof, acccroding to their taxonomic origin
M07K316/210:	. . from primates, i.e. including man
M07K316/220:	. . from camelids, e.g. camel, llama, dromedary
M07K316/230:	. . from birds
M07K316/240:	. . containing Ig-regions, -domains or -residues from different species, e.g. chimeric or humanised antibodies
M07K316/300:	. Bispecific or multispecific antibodies
M07K316/310:	. . Bispecific or multispecific diabodies, triabodies, etc.
M07K316/400:	. Immunoglobulins characterised by their degree fo glycosylation
M07K316/500:	. Immunoglobulins characterised by their fragments
M07K316/510:	. . Fd fragment
M07K316/520:	. . Constant or Fc region
M07K316/522:	. . . With modifications to decrease effector function, e.g. ADCC, CDC
M07K316/524:	. . . With modifications to enhance effector function, e.g. ADCC, CDC
M07K316/530:	. . Hinge region
M07K316/540:	. . F(ab')2 fragment
M07K316/550:	. . Fab fragment
M07K316/560:	. . Variable (Fv) region
M07K316/561:	. . . Single chain (scFv) antibodies
M07K316/563:	. . . Disulfide-stabilised (dsFv) antibodies
M07K316/565:	. . . Complementarity determining region (CDR)
M07K316/567:	. . . Framework region (FR)
M07K316/569:	. . . Single domain antibodies
M07K316/571:	. . with inserted heterologous non-lg peptide sequences, i.e. synthebodies
M07K316/600:	. Antibodies specific for a complex, e.g. antibody-antigen, ligand-recepto
M07K316/700:	. Scaffold molecules with antigen-binding properties, i.e. monobodies
M07K316/800:	. Intracellular antibodies, i.e. "intrabodies
M07K316/810:	. . functional in the endoplasmatic reticulum (ER) or the Golgi apparatu
M07K316/820:	. . functional in the cytoplasm, the inner aspect of the cell membrane, the nucleus, the mitochondri
M07K316/830:	. . characterised by their way of delivery into the cel
M07K316/900:	. Antibodies characterised by their affinit
M07K316/950:	. Antibodies with agonistic, e.g. apoptotic, activity upon their specific binding to an antigen
M07K316/960:	. Antibodies with antagonisticactivity upon their specific binding to an antigen
M07K317/00:	Immunoglobulins specific feautures
M07K317/100:	. characterized by their source of isolation or production
M07K317/110:	. . isolated from eggs
M07K317/120:	. . isolated from milk
M07K317/130:	. . isolated from plants
M07K317/140:	. . Specific host cells or culture conditions, e.g. components, pH or temperature
M07K317/200:	. characterized by taxonomic origin
M07K317/210:	. . from primates, e.g. man
M07K317/220:	. . from camelids, e.g. camel, llama or dromedary
M07K317/230:	. . from birds
M07K317/240:	. . containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
M07K317/300:	. characterized by aspects of specificity or valency
M07K317/310:	. . multispecific
M07K317/320:	. . specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
M07K317/330:	. . Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
M07K317/340:	. . Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
M07K317/350:	. . Valency
M07K317/400:	. characterized by post-translational modification
M07K317/410:	. . Glycosylation, sialylation, or fucosylation
M07K317/500:	. characterized by immunoglobulin fragments
M07K317/510:	. . Complete heavy chain or Fd fragment, i.e. VH + CH1
M07K317/515:	. . Complete light chain, i.e. VL + CL
M07K317/520:	. . Constant or Fc region; Isotype
M07K317/522:	. . . CH1 domain
M07K317/524:	. . . CH2 domain
M07K317/526:	. . . CH3 domain
M07K317/528:	. . . CH4 domain
M07K317/530:	. . . Hinge
M07K317/540:	. . F(ab')2
M07K317/550:	. . Fab or Fab'
M07K317/560:	. . variable (Fv) region , i.e. VH and/or VL
M07K317/565:	. . . Complementarity determining region (CDR)
M07K317/567:	. . . Framework region (FR)
M07K317/569:	. . . Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
M07K317/600:	. characterized by non-natural combinations of immunoglobulin fragments
M07K317/620:	. . comprising only variable region components
M07K317/622:	. . . Single chain antibody (scFv)
M07K317/624:	. . . Disulfide-stabilized antibody (dsFv)
M07K317/626:	. . . Diabody or triabody
M07K317/640:	. . comprising a combination of variable region and constant region components
M07K317/660:	. . comprising a swap of domains, e.g. CH3-CH2, VH-CL or VL-CH1
M07K317/700:	. characterized by effect upon binding to a cell or to an antigen
M07K317/710:	. . Decreased effector function due to an Fc-modification
M07K317/720:	. . Increased effector function due to an Fc-modification
M07K317/730:	. . Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
M07K317/732:	. . . Antibody-dependent cellular cytotoxicity (ADCC)
M07K317/734:	. . . Complement-dependent cytotoxicity (CDC)
M07K317/740:	. . Inducing cell proliferation
M07K317/750:	. . Agonist effect on antigen
M07K317/760:	. . Antagonist effect on antigen, e.g. neutralization or inhibition of binding
M07K317/770:	. . Internalization into the cell
M07K317/800:	. remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies
M07K317/810:	. . functional in the endoplasmatic reticulum (ER) or the Golgi apparatus
M07K317/820:	. . functional in the cytoplasm, the inner aspect of the cell membrane, the nucleus or the mitochondria
M07K317/900:	. characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
M07K317/920:	. . Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
M07K317/940:	. . Stability, e.g. half-life, pH, temperature or enzyme-resistance
M07K318/00:	Antibody mimetics or scaffolds
M07K318/100:	. Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
M07K318/200:	. Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
M07K319/00:	Fusion polypeptide
M07K319/00E:	. containing an enzyme part without its signal sequence
M07K319/00E2:	. . containing an enzyme signal sequence possibly accompanied by part or the whole of the mature enzyme
M07K319/01:	. containing a localisation/targetting motif
M07K319/02:	. . containing a signal sequence
M07K319/03:	. . containing a transmembrane segment
M07K319/033:	. . containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
M07K319/034:	. . containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
M07K319/035:	. . containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
M07K319/036:	. . targeting to the medium outside of the cell, e.g. type III secretion
M07K319/04:	. . containing an ER retention signal such as a C-terminal HDEL motif
M07K319/05:	. . containing a GOLGI retention signal
M07K319/055:	. . containing a signal for localisation to secretory granules
M07K319/06:	. . containing a lysosomal/endosomal localisation signal
M07K319/07:	. . containing a mitochondrial localisation signal
M07K319/08:	. . containing a chloroplats localisation signal
M07K319/09:	. . containing a nuclear localisation signal
M07K319/095:	. . containing a nuclear export signal
M07K319/10:	. . containing a tag for extracellular membrane crossing, e.g. TAT or VP22
M07K319/20:	. containing a tag with affinity for a non-protein ligand
M07K319/21:	. . containing a His-tag
M07K319/22:	. . containing a Strep-tag
M07K319/23:	. . containing a GST-tag
M07K319/24:	. . containing a MBP(maltose binding protein)-tag
M07K319/30:	. Non-immunoglobulin-derived peptide or protein having an imunoglobulin constant or Fc region, or a fragment thereof, attached thereto
M07K319/31:	. fusions, other than Fc, for prolonged plasma life, e.g. albumin
M07K319/32:	. fusions with soluble part of a cell surface receptor, "decoy receptors"
M07K319/33:	. fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
M07K319/35:	. containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
M07K319/40:	. containing a tag for immunodetection, or an epitope for immunisation
M07K319/41:	. . containing a Myc-tag
M07K319/42:	. . containing a HA(hemagglutinin)-tag
M07K319/43:	. . containing a FLAG-tag
M07K319/50:	. containing protease site
M07K319/55:	. containing a fusion with a toxin, e.g. diphteria toxin
M07K319/60:	. containing spectroscopic/fluorescent detection, e.g. green fluorescent protein (GFP)
M07K319/61:	. containing an enzyme fusion for detection
M07K319/70:	. containing domain for protein-protein interaction
M07K319/705:	. . containing a protein-A fusion
M07K319/71:	. . containing domain for transcriptional activaation, e.g. VP16
M07K319/715:	. . . containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
M07K319/72:	. . containing SH2 domain
M07K319/73:	. . containing coiled-coiled motif (leucine zippers)
M07K319/735:	. . containing a domain for self-assembly, e.g. a viral coat protein
M07K319/74:	. . containing a fusion for binding to a cell surface receptor
M07K319/75:	. . . containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
M07K319/80:	. containing a DNA binding domain, e.g. Lacl or Tet-repressor
M07K319/81:	. . containing a Zn-finger domain for DNA binding
M07K319/85:	. containing an RNA binding domain
M07K319/90:	. containing a motif for post-translational modification
M07K319/91:	. . containing a motif for glycosylation
M07K319/912:	. . . containing a GPI anchor
M07K319/915:	. . containing a motif for acylation
M07K319/92:	. . containing an intein domain
M07K319/95:	. containing a motif/fusion for degradation